Castration-resistant prostate cancer management
The Editors of Prostate Cancer and Prostatic Diseases (PCAN) are proud to present a special collection on 'Castration-resistant prostate cancer (CRPC) management'. We feature papers from the last seven years by some of the top scientists in the field, which highlight and provide novel insights into important clinical and translational advances in the management of CRPC.
Particularly three topics have been considered.
- Concomitant Sequential Treatment in CRPC
- New Therapeutic agents
- The impact of ARTA and tumour’s characteristics on treatment outcome
Cosimo De Nunzio, Andrew J. Amstrong, Inge Van Oort & Tanya Dorff
